SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950112-96-000441
Filing Date
1996-02-14
Accepted
1996-02-14 00:00:00
Documents
1
Group Members
MERRILL LYNCH & CO INCMERRILL LYNCH, PIERCE, FENNER & SMITH
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 MERRILL LYNCH & CO., INC. SC 13G/A 24097
  Complete submission text file 0000950112-96-000441.txt   26182
Mailing Address 250 VESEY ST WORLD FINANCIAL CTR N TOWER NEW YORK NY 10281-1334
Business Address 250 VESEY ST WORLD FINANCIAL CTR N TOWER NEW YORK NY 10281-1334 2124491000
MERRILL LYNCH & CO INC (Filed by) CIK: 0000065100 (see all company filings)

IRS No.: 132740599 | State of Incorp.: DE | Fiscal Year End: 1228
SIC: 6211 Security Brokers, Dealers & Flotation Companies

Mailing Address
Business Address 1375 CALIFORNIA AVENUE P O BOX 10051 PALO ALTO CA 94303 4154968200
THERAPEUTIC DISCOVERY CORP (Subject) CIK: 0000899753 (see all company filings)

IRS No.: 943173191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-45501 | Film No.: 96520131
SIC: 2834 Pharmaceutical Preparations